To investigate the potential involvement of T helper (Th)2-type responses in murine models of intestinal inflammation, we used trinitrobenzene sulfonic acid (TNBS)–hapten to induce inflammatory bowel disease in situations where Th1-type responses with interferon (IFN)-γ synthesis are either diminished or do not occur. Intracolonic administration of TNBS to either normal (IFN-γ+/+) or Th1-deficient IFN-γ knockout (IFN-γ−/−) BALB/c mice resulted in significant colitis. In IFN-γ−/− mice, crypt inflammation was more severe than in IFN-γ+/+ mice and was accompanied by hypertrophy of colonic patches with a lymphoepithelium containing M cells and distinct B and T cell zones resembling Peyer's patches. Hapten-specific, colonic patch T cells from both mouse groups exhibited a Th2 phenotype with interleukin (IL)-4 and IL-5 production. TNBS colitis in normal mice treated with anti–IL-4 antibodies or in IL-4−/− mice was less severe than in either IFN-γ+/+ or IFN-γ−/− mice. Our findings now show that the Th2-type responses in TNBS colitis are associated with colonic patch enlargement and inflammation of the mucosal layer and may represent a model for ulcerative colitis.
Skip Nav Destination
Article navigation
19 April 1999
Article|
April 19 1999
Hapten-induced Colitis Is Associated with Colonic Patch Hypertrophy and T Helper Cell 2–Type Responses
Taeko Dohi,
Taeko Dohi
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Search for other works by this author on:
Kohtaro Fujihashi,
Kohtaro Fujihashi
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Search for other works by this author on:
Paul D. Rennert,
Paul D. Rennert
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Search for other works by this author on:
Koichi Iwatani,
Koichi Iwatani
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Search for other works by this author on:
Hiroshi Kiyono,
Hiroshi Kiyono
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Search for other works by this author on:
Jerry R. McGhee
Jerry R. McGhee
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Search for other works by this author on:
Taeko Dohi
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Kohtaro Fujihashi
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Paul D. Rennert
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Koichi Iwatani
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Hiroshi Kiyono
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Jerry R. McGhee
From the *Immunobiology Vaccine Center, Department of Microbiology and ‡Department of Oral Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294; §Biogen Incorporated, Cambridge, Massachusetts 02142; and the ¶Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan
Address correspondence to Dr. Jerry R. McGhee, The Immunobiology Vaccine Center and the Department of Microbiology, the University of Alabama at Birmingham, 761 Bevill Biomedical Research Building, 845 19th Street South, Birmingham, AL 35294-2170. Phone: 205-934-5045; Fax: 205-975-4431; E-mail: [email protected]
Received:
March 02 1998
Revision Received:
February 25 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (8): 1169–1180.
Article history
Received:
March 02 1998
Revision Received:
February 25 1999
Citation
Taeko Dohi, Kohtaro Fujihashi, Paul D. Rennert, Koichi Iwatani, Hiroshi Kiyono, Jerry R. McGhee; Hapten-induced Colitis Is Associated with Colonic Patch Hypertrophy and T Helper Cell 2–Type Responses . J Exp Med 19 April 1999; 189 (8): 1169–1180. doi: https://doi.org/10.1084/jem.189.8.1169
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement